VVOS - Vivos Therapeutics, Inc. Book Valuation of Business
The share price of Vivos Therapeutics (VVOS), currently trading at -0.01 as illustrated below, is supported by the stable operation of its precision dental device manufacturing plants. Vivos Therapeutics (VVOS) is creating a closed-loop sleep apnea therapy cycle by integrating cloud services, proprietary CARE devices, and medical professional certification. This approach to sleep health via physician training renders their methodology a unique solution for snoring.
%20Company%20Book%20Value&width=1200&height=400&colorIndex=0&v=mvrk6wqv.ssk-7as46ww&start=20220704&end=20261028&filename=GURU_Markets_-_VVOS_-_Vivos-Therapeutics_-_Company-Book-Value "Vivos Therapeutics, Inc - VVOS Book Valuation of Business (period 07/04/2022 - 10/28/2026) | 👁️GURU.Markets👁️")
Financial and market metric breakdowns for Vivos Therapeutics, Inc. (VVOS)
Book value determines the net value of assets minus liabilities, serving as a leading indicator of the market risk of failing to meet planned targets. By analyzing the capital dynamics in the balance sheet of Vivos Therapeutics (VVOS), an investor assesses the financial stability of the company, which relies on organic demand and physician partnerships without pursuing M&A deals, allowing for the identification of overvaluation and the avoidance of loss-making investments.